7Baggers
 Verrica Pharmaceuticals Reports Q3 2025 Earnings  TipRanks Tue, 18 Nov 2025 03:55:58 GMT
 Verrica Pharmaceuticals earnings beat by $0.21, revenue topped estimates  Investing.com Nigeria Sat, 15 Nov 2025 00:59:35 GMT
 verrica pharmaceuticals earnings beat by $0.21, revenue topped estimates  Investing.com UK Fri, 14 Nov 2025 22:55:00 GMT
 Verrica Swings Closer To Profit On Rising YCANTH Sales  Finimize Fri, 14 Nov 2025 22:53:56 GMT
 Verrica Pharmaceuticals (VRCA) Reports Strong Q3 Revenue, Surpas  GuruFocus Fri, 14 Nov 2025 21:37:38 GMT
 Verrica Pharmaceuticals Q3 net loss narrows  MarketScreener Fri, 14 Nov 2025 21:17:50 GMT
 Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results  GlobeNewswire Fri, 14 Nov 2025 21:05:00 GMT
 Verrica Pharmaceuticals Q3 2025 Earnings Call Transcript  MarketBeat Fri, 14 Nov 2025 01:01:06 GMT
 verrica swings closer to profit on rising ycanth sales  Finimize Thu, 13 Nov 2025 23:59:23 GMT
 Verrica Pharmaceuticals (VRCA) Showcases Promising Data for VP-3  GuruFocus Mon, 10 Nov 2025 13:46:27 GMT
 Verrica Pharmaceuticals Presents New Data on VP-315 from  GlobeNewswire Mon, 10 Nov 2025 13:00:00 GMT
 published on: 2025-11-06 06:00:16  newser.com Thu, 06 Nov 2025 12:00:16 GMT
 Verrica Pharmaceuticals initiated with a Buy at Lucid Capital  TipRanks Wed, 05 Nov 2025 08:00:00 GMT
 published on: 2025-11-02 22:31:17  newser.com Mon, 03 Nov 2025 03:31:17 GMT

Verrica Pharmaceuticals Inc
(NASDAQ:VRCA) 

VRCA stock logo

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; which has completed phase II clinical trial fo...

Founded: 2013
Full Time Employees: 17
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends